MHRA consultation outcome
On 31 May 2022 the MHRA launched a consultation on “The future strategy for batch testing of medicinal products in Great Britain”.?This consultation closed on 26 July 2022.?This consultation gave 4 options.
On 15 December the MHRA published the outcome of this consultation, which is that the government has decided to make permanent the approach of maintaining a list of approved countries for import which require no import testing or UK?QP?certification (i.e. option A in the consultation).
Expert consultant in pharmaceutical quality and compliance Consultor en calidad farmaceutica
2 年Bad news.
PharmD | MSc | MRPharmS | CQP MCQI | MRQA | Senior Director, Global Quality Management System at Amicus Therapeutics
2 年Good news.